Oncternal Therapeutics In...
(ONCT)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
Revenue | 785.00K | 1.49M | 4.32M | 3.38M | 2.42M | 2.52M | 1.67M | -2.51M | - | - | - | - | 14.74M | 60.61M | 14.73M | 13.53M | 7.13M | 7.50M | 3.78M | 1.87M | - | - | - | - | - |
Cost of Revenue | 29.75M | 179.00K | 169.00K | 12.00M | 10.16M | 46.00K | 47.00K | 2.51M | 43.00K | - | - | - | 1.05M | 768.00K | 1.29M | 649.00K | 621.00K | 773.00K | 1.57M | - | - | - | - | - | - |
Gross Profit | -28.97M | 1.31M | 4.15M | -8.63M | -7.73M | 2.48M | 1.63M | -5.02M | -43.00K | - | - | - | 13.68M | 59.84M | 13.44M | 12.88M | 6.50M | 6.73M | 2.21M | 1.87M | - | - | - | - | - |
Operating Income | -41.71M | -44.95M | -31.37M | -17.54M | -33.11M | -39.06M | -30.66M | -25.93M | -21.84M | -30.35M | -43.60M | -49.73M | -33.69M | 13.93M | -46.65M | -54.48M | -45.50M | -38.52M | -38.56M | -23.29M | -14.34M | -12.02M | -8.15M | -3.96M | -819.00K |
Interest Income | 2.23M | 777.00K | 33.00K | 16.00K | 188.00K | - | - | - | - | - | - | - | - | - | 159.00K | 2.71M | 5.14M | 3.01M | 1.72M | 946.00K | 143.00K | - | 83.00K | - | - |
Pretax Income | -39.48M | -44.17M | -31.33M | -17.23M | -34.19M | -38.42M | -30.44M | -17.72M | -18.70M | -39.41M | -42.11M | -49.75M | -33.29M | 15.29M | -46.49M | -51.78M | -40.36M | -35.51M | -36.84M | -5.68M | -95.47M | - | - | - | - |
Net Income | -39.48M | -43.39M | -31.30M | -17.21M | -15.91M | -38.42M | -30.44M | -17.72M | -18.70M | -39.41M | -42.11M | -27.07M | -33.29M | 15.29M | -46.26M | -51.78M | -40.36M | -35.51M | -36.84M | -22.35M | -14.19M | -11.87M | -8.06M | -3.81M | -750.00K |
Selling & General & Admin | 12.75M | 13.46M | 11.60M | 8.37M | 7.29M | 9.39M | 9.19M | 8.71M | 8.23M | 9.48M | 11.28M | 10.85M | 15.44M | 17.42M | 27.75M | 23.11M | 13.50M | 11.35M | 9.85M | 7.21M | 3.51M | 2.40M | 2.23M | 1.20M | 256.00K |
Research & Development | 29.75M | 32.98M | 24.09M | 12.54M | 10.16M | 29.67M | 21.47M | 17.23M | 13.61M | 20.87M | 32.32M | 38.89M | 31.94M | 28.50M | 32.34M | 44.26M | 38.51M | 33.90M | 30.92M | 17.95M | 10.47M | 9.29M | 5.92M | 2.68M | 518.00K |
Other Expenses | -29.75M | -1.49M | -4.32M | -3.38M | -2.42M | 641.00K | 216.00K | 46.00K | 57.00K | -259.00K | 1.49M | -19.00K | 15.44M | - | - | - | 13.50M | 11.35M | 9.85M | 7.21M | 357.00K | - | - | - | - |
Operating Expenses | 12.75M | 44.95M | 31.37M | 17.54M | 15.02M | 39.06M | 30.66M | 25.93M | 21.84M | 30.35M | 43.60M | 49.73M | 47.38M | 45.91M | 60.09M | 67.36M | 52.01M | 45.25M | 40.77M | 25.16M | 14.34M | 12.02M | 8.15M | 3.96M | 819.00K |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | 200.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 42.50M | 44.95M | 31.37M | 17.54M | 15.02M | 39.06M | 30.66M | 25.93M | 21.84M | 30.35M | 43.60M | 49.73M | 48.43M | 46.68M | 61.38M | 68.01M | 52.63M | 46.02M | 42.34M | 25.16M | 14.34M | 12.02M | 8.15M | 3.96M | 819.00K |
Income Tax | - | -777.00K | -33.00K | -16.00K | -18.28M | 641.00K | -47.00K | -8.19M | -3.12M | 8.70M | -384.00K | -8.82M | -1.44M | -2.94M | -238.00K | -1.56M | 4.90M | -72.03M | 299.00K | 17.25M | -143.00K | -156.00K | 8.06M | -150.00K | -69.00K |
Shares Outstanding (Basic) | 2.94M | 2.63M | 2.47M | 1.02M | 516.45K | 3.34M | 2.49M | 2.08M | 2.01M | 1.17M | 900.82K | 897.27K | 819.42K | 555.35K | 520.22K | 518.59K | 499.14K | 445.00K | 371.18K | 328.47K | 110.50K | 110.50K | 110.68K | 110.50K | 110.50K |
Shares Outstanding (Diluted) | 2.94M | 2.63M | 2.47M | 1.02M | 516.45K | 3.34M | 2.49M | 2.08M | 2.11M | 1.17M | 900.82K | 897.27K | 819.42K | 555.35K | 520.22K | 518.59K | 499.14K | 445.00K | 371.18K | 343.75K | 110.50K | 110.50K | 110.68K | 110.50K | 110.50K |
EPS (Basic) | -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -9.33 | -33.72 | -46.75 | -30.17 | -40.63 | 27.30 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -68.04 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
EPS (Diluted) | -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -8.86 | -33.72 | -46.75 | -30.17 | -40.63 | 27.30 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -65.01 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
EBITDA | 2.23M | -44.95M | -31.37M | -17.54M | -33.11M | 1.01M | -30.39M | -17.70M | -18.66M | -39.31M | -41.73M | -49.00M | -34.09M | 16.87M | -44.71M | -52.92M | -45.50M | -34.37M | -38.56M | -23.29M | - | -11.69M | -8.15M | -3.88M | -774.00K |
Depreciation & Amortization | 41.71M | 179.00K | 169.00K | 150.00K | 15.02M | 7.59M | 47.00K | 28.00K | 43.00K | 102.00K | 384.00K | 750.00K | 1.04M | 1.57M | 1.78M | 1.56M | -4.90M | -5.01M | -299.00K | -580.00K | 357.00K | 332.00K | - | 80.00K | 45.00K |